COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. Weckmann M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al. Eur Respir J 2021 Jul 29. pii: 13993003.03969-2020.

Read + Share

Amedeo Smart

Independent Medical Education

Weckmann M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al. COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy. Eur Respir J 2021 Jul 29. pii: 13993003.03969-2020.
PMID: 34326188